AU2003230935B2 - Methods of simultaneously treating ocular rosacea and acne rosacea - Google Patents

Methods of simultaneously treating ocular rosacea and acne rosacea Download PDF

Info

Publication number
AU2003230935B2
AU2003230935B2 AU2003230935A AU2003230935A AU2003230935B2 AU 2003230935 B2 AU2003230935 B2 AU 2003230935B2 AU 2003230935 A AU2003230935 A AU 2003230935A AU 2003230935 A AU2003230935 A AU 2003230935A AU 2003230935 B2 AU2003230935 B2 AU 2003230935B2
Authority
AU
Australia
Prior art keywords
hydrogen
amino
halogen
dimethylamino
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2003230935A
Other languages
English (en)
Other versions
AU2003230935A1 (en
Inventor
Robert A. Ashley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Collagenex Pharmaceuticals Inc
Original Assignee
Collagenex Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Collagenex Pharmaceuticals Inc filed Critical Collagenex Pharmaceuticals Inc
Publication of AU2003230935A1 publication Critical patent/AU2003230935A1/en
Application granted granted Critical
Publication of AU2003230935B2 publication Critical patent/AU2003230935B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003230935A 2002-04-16 2003-04-16 Methods of simultaneously treating ocular rosacea and acne rosacea Ceased AU2003230935B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US37314102P 2002-04-16 2002-04-16
US60/373,141 2002-04-16
PCT/US2003/011686 WO2003088906A2 (en) 2002-04-16 2003-04-16 Methods of simultaneously treating ocular rosacea and acne rosacea

Publications (2)

Publication Number Publication Date
AU2003230935A1 AU2003230935A1 (en) 2003-11-03
AU2003230935B2 true AU2003230935B2 (en) 2008-08-07

Family

ID=29250974

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003230935A Ceased AU2003230935B2 (en) 2002-04-16 2003-04-16 Methods of simultaneously treating ocular rosacea and acne rosacea

Country Status (8)

Country Link
US (1) US7008631B2 (cg-RX-API-DMAC10.html)
EP (2) EP2368557A1 (cg-RX-API-DMAC10.html)
JP (1) JP2005523313A (cg-RX-API-DMAC10.html)
KR (1) KR20050005444A (cg-RX-API-DMAC10.html)
AU (1) AU2003230935B2 (cg-RX-API-DMAC10.html)
CA (1) CA2476792A1 (cg-RX-API-DMAC10.html)
NZ (1) NZ534613A (cg-RX-API-DMAC10.html)
WO (1) WO2003088906A2 (cg-RX-API-DMAC10.html)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2447008A1 (en) * 2001-04-05 2002-10-24 Collagenex Pharmaceuticals, Inc. Controlled delivery of tetracycline compounds and tetracycline derivatives
US7211267B2 (en) * 2001-04-05 2007-05-01 Collagenex Pharmaceuticals, Inc. Methods of treating acne
US8192749B2 (en) * 2003-04-16 2012-06-05 Galderma Laboratories Inc. Methods of simultaneously treating ocular rosacea and acne rosacea
CA2521885C (en) * 2003-04-07 2013-06-25 Shire Laboratories, Inc. Once daily formulations of tetracyclines
NZ544826A (en) * 2003-07-25 2008-07-31 Warner Chilcott Co Inc A doxycycline metal complex in a solid dosage form
CA2558015A1 (en) * 2004-03-12 2005-09-29 Collagenex Pharmaceuticals, Inc. Method for treating aortic stenosis with non-antibacterial tetracycline formulations
US7544373B2 (en) 2007-04-02 2009-06-09 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US20080241235A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US20080242642A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US7919483B2 (en) * 2005-06-24 2011-04-05 Medicis Pharmaceutical Corporation Method for the treatment of acne
US8252776B2 (en) 2007-04-02 2012-08-28 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US9192615B2 (en) 2008-08-06 2015-11-24 Medicis Pharmaceutical Corporation Method for the treatment of acne and certain dosage forms thereof
US7541347B2 (en) 2007-04-02 2009-06-02 Medicis Pharmaceutical Coropration Minocycline oral dosage forms for the treatment of acne
US8722650B1 (en) 2005-06-24 2014-05-13 Medicis Pharmaceutical Corporation Extended-release minocycline dosage forms
IL270446B2 (en) 2006-12-21 2023-10-01 Paratek Pharm Innc A tetracycline compound, a pharmaceutical preparation containing the tetracycline compound, and the tetracycline compound or the pharmaceutical preparation for the treatment of the tetracycline-responsive condition
PL2120963T3 (pl) * 2006-12-21 2019-05-31 Paratek Pharm Innc Podstawione związki tetracyklinowe do leczenia zaburzeń zapalnych skóry
US20080312194A1 (en) * 2007-02-28 2008-12-18 Ousler Iii George W Methods and compositions for normalizing meibomian gland secretions
US20080241197A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline dosage forms for the treatment of acne
WO2008121107A1 (en) * 2007-04-02 2008-10-09 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US20080305186A1 (en) * 2007-06-11 2008-12-11 Board Of Regents, The University Of Texas System Method and Composition for the Treatment of Cardiac Hypertrophy
US8107283B2 (en) * 2009-01-12 2012-01-31 Macronix International Co., Ltd. Method for setting PCRAM devices
US9561241B1 (en) 2011-06-28 2017-02-07 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for minocycline
US9119793B1 (en) 2011-06-28 2015-09-01 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for doxycycline
WO2013113067A1 (en) * 2012-02-02 2013-08-08 The University Of Sydney Improvements in tear film stability
FR3000396A1 (fr) * 2012-12-31 2014-07-04 Galderma Res & Dev Combinaison de laropiprant et de doxycycline pour le traitement de la rosacee
US10842802B2 (en) 2013-03-15 2020-11-24 Medicis Pharmaceutical Corporation Controlled release pharmaceutical dosage forms
FR3026010B1 (fr) * 2014-09-18 2016-11-04 Galderma Sa Compositions comprenant un compose de la famille des avermectines et de la doxycycline pour le traitement de la rosacee
FR3064482B1 (fr) * 2017-04-03 2020-11-13 Horus Pharma Composition topique de doxycycline
MX2020007222A (es) * 2018-01-07 2020-12-10 Dr Reddys Laboratories Ltd Metodos para el tratamiento de afecciones inflamatorias de la piel.
EP3852734A1 (en) * 2018-09-22 2021-07-28 Novaliq GmbH Ophthalmic compositions for treatment of ocular surface damage and symptoms of dryness
CN111499545B (zh) * 2020-04-27 2022-05-03 武汉英纳氏药业有限公司 一种对氨基取代苯酚类化合物的制备方法
WO2024008951A1 (en) * 2022-07-08 2024-01-11 Icm (Institut Du Cerveau Et De La Moelle Épinière) Tetracycline derivatives

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5908838A (en) * 1998-02-19 1999-06-01 Medics Pharmaceutical Corporation Method for the treatment of acne
WO1999058131A1 (en) * 1998-05-08 1999-11-18 University Of Miami Use of tetracyclines for treating meibomian gland disease
US6015803A (en) * 1998-05-04 2000-01-18 Wirostko; Emil Antibiotic treatment of age-related macular degeneration

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4957918A (en) * 1988-06-09 1990-09-18 Leonard Bloom Topical treatment of blepharitis
US5827840A (en) * 1996-08-01 1998-10-27 The Research Foundation Of State University Of New York Promotion of wound healing by chemically-modified tetracyclines
US6071541A (en) * 1998-07-31 2000-06-06 Murad; Howard Pharmaceutical compositions and methods for managing skin conditions
US6432934B1 (en) 1998-08-06 2002-08-13 Advanced Vision Research Methods and compositions for topical treatment of eye surface inflammation and related dry eye disease
US6384081B2 (en) * 1998-10-09 2002-05-07 Charles L. Berman Treatment of diseases of the eye characterized by the formation of metalloproteinase
US6664287B2 (en) * 2000-03-15 2003-12-16 Bethesda Pharmaceuticals, Inc. Antioxidants
US6495158B1 (en) * 2001-01-19 2002-12-17 Lec Tec Corporation Acne patch
EP1716856A3 (en) * 2001-04-05 2009-02-18 Collagenex Pharmaceuticals, Inc. The treatment of acne
US20040092491A1 (en) * 2002-11-09 2004-05-13 The Research Foundation Of State University Of New York Method of treating sepsis-induced ARDS

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5908838A (en) * 1998-02-19 1999-06-01 Medics Pharmaceutical Corporation Method for the treatment of acne
US6015803A (en) * 1998-05-04 2000-01-18 Wirostko; Emil Antibiotic treatment of age-related macular degeneration
WO1999058131A1 (en) * 1998-05-08 1999-11-18 University Of Miami Use of tetracyclines for treating meibomian gland disease

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Freinkel, et al. new England Journal of Medicine. Vol.273(16): 850-854. 1965. *

Also Published As

Publication number Publication date
NZ534613A (en) 2007-07-27
JP2005523313A (ja) 2005-08-04
WO2003088906A2 (en) 2003-10-30
EP1494681A4 (en) 2008-08-06
US20030229055A1 (en) 2003-12-11
EP1494681A2 (en) 2005-01-12
EP2368557A1 (en) 2011-09-28
KR20050005444A (ko) 2005-01-13
WO2003088906A3 (en) 2004-02-26
CA2476792A1 (en) 2003-10-30
AU2003230935A1 (en) 2003-11-03
US7008631B2 (en) 2006-03-07

Similar Documents

Publication Publication Date Title
US7008631B2 (en) Methods of simultaneously treating ocular rosacea and acne rosacea
US20120220555A1 (en) Methods of Simultaneously Treating Ocular Rosacea and Acne Rosacea
CA2485677C (en) Methods of treating allergic reactions
AU2002303250B2 (en) Methods of treating acne
US20050153943A1 (en) Methods of simultaneously treating mucositis and fungal infection
AU2002303250A1 (en) Methods of treating acne
US20070015738A1 (en) Use of non-antibacterial tetracycline formulations for inhibiting bacterial spores from becoming infectious vegetative cells
WO2005082860A1 (en) Tetracyclines and their use as calpain inhibitors
JP2001048799A (ja) ダニアレルギー治療剤
HK124595A (en) Anthocyanidins for the treatment of ophthalmic diseases
US20070010498A1 (en) Method for reducing blood loss associated with cardio-pulmonary bypass surgery
EP1296703B1 (en) Non-antibacterial tetracycline as anti-fungal agents
MXPA06010404A (es) Metodo para tratar la estenosis aortica con formulaciones de tetraciclina no anti-bacterianas.
ITRM940625A1 (it) Uso di esteri ftalidilidenici della carnitina e di alcanoil carnitine per il trattamento dello shock endotossico
KR20080034434A (ko) 세균 포자를 억제하기 위한 비항균성 테트라사이클린제형의 용도
CA2502729A1 (en) Use of heterocyclic amine-type compounds as neuroprotective agents

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired